June 25, 2017 10:09 PM ET

Personal Products

Company Overview of MYOS RENS Technology Inc.

Executive Profile

Robert Joseph Hariri M.D., Ph.D.

Executive Chairman and Chairman of the Scientific Advisory Board, MYOS RENS Technology Inc.
AgeTotal Calculated CompensationThis person is connected to 12 Board Members in 12 different organizations across 14 different industries.

See Board Relationships
57$14,694

Background

Dr. Robert Joseph Hariri, also known as Bob, M.D., Ph.D. is a Co-Founder of Human Longevity, Inc. and serves as President of Human Longevity Cellular Therapeutics. Dr. Hariri is Founder of Celgene Cellular Therapeutics, Inc. (formerly, Anthrogenesis Corporation) and serves as its Chief Scientific Officer. Dr. Hariri serves as the Chief Executive Officer of LifebankUSA Inc. He has been Executive Chairman of the Board at MYOS RENS Technology Inc. since April 2012. His ...

Corporate Headquarters

45 Horsehill Road
Cedar Knolls, New Jersey 07927

United States

Phone: 973-509-0444
Fax: --

Board Members Memberships

Director
Director
Director
Director
Director
2007-Present
Director
2007-Present
Director
2010-Present
Director
2011-Present
Executive Chairman and Chairman of the Scientific Advisory Board
2015-Present
Independent Director
2015-Present
Independent Director
2017-Present
Co-Founder, President of Human Longevity Cellular Therapeutics and Director

Education

PhD
Cornell University
Bachelor's Degree
Cornell University
BA
Columbia College Chicago

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$10,308
Total Calculated Compensation$14,694
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James Robert B. Quincey Chief Executive Officer, President and Director
The Coca-Cola Company
$923.6K
Miles D. White Chairman of the Board & Chief Executive Officer
Abbott Laboratories
$1.9M
Emma Walmsley Chief Executive Officer & Director
GlaxoSmithKline plc
--
Siobhan Talbot B.Comm, FCAGroup Managing Director and Executive Director
Glanbia plc
$1.8M
Robert F. Moran Interim Chief Executive Officer and Director
GNC Holdings, Inc.
$865.0K
Compensation as of Fiscal Year 2016.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact MYOS RENS Technology Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.